Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04058795 · ClinicalTrials.gov registry record · NA
PTSD Mobile App for Cancer Survivors
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 524
- Enrollment target
NCT04058795 is a NA study that has completed, run by Duke University. The registered enrollment target is 524 participants.
The verdict
NCT04058795, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 524 participants
- Enrollment target
Study Summary
The purpose of this study is to use a stepped-care approach in treating symptoms of posttraumatic stress disorder (PTSD). The information learned by doing this study may help us to develop some target treatments for PTSD symptoms in survivors of stem cell transplant. Participants in this study will be randomized to a mobile app or usual care. An assessment will be made after 4 weeks and a determination made of adding more intensive treatment. Participants will be asked to complete a questionnaire 4 times over a period of 6 months, at the time your participation is complete.
Interventions
- BEHAVIORAL Cancer Distress Coach (CaDC) App
- BEHAVIORAL CaDC + mCoaching
- BEHAVIORAL mCBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 524 participants |
| Start Date | 2021-01-24 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04058795
The ClinicalTrials.gov registry entry for NCT04058795 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 524 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cancer Distress Coach (CaDC) App is the first listed.
NCT04058795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04058795 about?
NCT04058795 is a clinical study titled "PTSD Mobile App for Cancer Survivors". The purpose of this study is to use a stepped-care approach in treating symptoms of posttraumatic stress disorder (PTSD). The information learned by doing this study may help us to develop some target treatments for PTSD symptoms in survivors of stem cell transplant. Participants in this study will...
What is the current status of trial NCT04058795?
This trial is currently completed. It is a NA study. The enrollment target is 524 participants. The study started on 2021-01-24. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT04058795?
The interventions under investigation include: Cancer Distress Coach (CaDC) App (BEHAVIORAL), CaDC + mCoaching (BEHAVIORAL), mCBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT04058795?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.